<DOC>
	<DOCNO>NCT00940823</DOCNO>
	<brief_summary>The purpose study compare safety efficacy Ahmed valve Baerveldt implant treat refractory glaucoma . Eligible patient recruit multiple study center randomize glaucoma drainage device implantation . They follow long-term base upon outcome measure include intraocular pressure , glaucoma medication use , visual acuity , complication surgery treatment require .</brief_summary>
	<brief_title>The AVB Study : Prospective Study Comparing Ahmed Valve Baerveldt Implant Treating Refractory Glaucoma</brief_title>
	<detailed_description>Introduction : The use glaucoma drainage device ( GDD ) indicate case refractory glaucoma responsive conventional medication , laser surgical therapy . Most patient high risk surgical failure , serious concomitant ocular systemic disease . GDD 's increasingly use obtain low target intraocular pressure ( IOP ) patient fail antimetabolite trabeculectomy active neovascular glaucoma . Since Molteno 's original design , several drainage device become commercially available implantation . Currently , two commonly use device Ahmed Glaucoma Valve ( AGV ) ( New World Medical , Inc. , Rancho Cucamonga , CA ) , Baerveldt Glaucoma Device ( BGD ) ( Advanced Medical Optics , Santa Ana , CA ) . The AGV , venture-based flow-restrictive valve helpful minimize postoperative hypotony complication associate hypotony , include flat anterior chamber , choroidal effusion , suprachoroidal hemorrhage . However , appear high rate encapsulation hypertension associate device , increase requirement postoperative glaucoma medication use . The BGD , non-valved device , require early ligature flow use suture restriction allow adequate time bleb formation . Although result initial post-operative hypertension phase , result le encapsulation theoretically few postoperative glaucoma medication well IOP control . However , lack flow-restrictor large filter surface area may result great risk hypotony relate complication . Although several study compare AGV BGD report , retrospective , nonrandomized , small scale , compare different patient population . The result inconclusive conflict evaluate relative efficacy characteristic two device , research need do order answer question . Objective : The Ahmed vs. Baerveldt ( AVB ) Study first multicenter prospective randomize clinical trial comparing Ahmed FP7 valve Baerveldt-350 tube shunt glaucoma drainage device . Primary outcome surgical failure , composite criterion evaluate intraocular pressure lower effect device , complication surgery , treatment complication , glaucoma medication use , preservation visual acuity . Secondary outcome evaluate variable individually , non-glaucoma related ocular pathology require intervention . AVB Study Manual : An AVB Study Manual include study design protocol , standardized surgical technique , patient education consent form , data collection protocol distribute clinical site . The content manual receive ethic approval Institutional Review Board ( IRB ) primary site . Study Organization : 1 . Investigator Committee ( IC ) : Composed study investigator leadership Study Chair . The IC 's responsibility define : 1 . Designing study protocol ensure valid scientific method proper ethical conduct . 2 . Overseeing clinical center ensure protocol ethical standard study uphold . 3 . Overseeing Data Acquisition &amp; Statistical Center ensure practice accordance outline protocol , meet ethical standard study . 4 . Drafting edit study document critically intellectual content ethical consideration . 2 . Clinical Centers ( CC ) : Composed study site lead Site Primary Investigator , whose responsibility define : 1 . Enrolling patient study determine eligibility provide patient education . Informed consent must write . 2 . Ensuring study protocol ethical standard study uphold . 3 . Ensuring study adheres policy set forth local Institutional/Ethical Review Board . 4 . Acquiring study data make available Data Monitoring &amp; Statistics Committee . 3 . Data Acquisition &amp; Statistical Center ( DASC ) : Composed Study Director Study Statistician , follow responsibility : 1 . Acquiring study data Clinical Center use online study database ( http : //www.avsbstudy.com ) 2 . Statistical analysis study data . Methods : Patient Enrollment Treatment Assignment : Patients recruit 7 study site 10 surgeon . After patient eligibility write informed consent obtain Site PI , randomization placement Ahmed FP7 valve Baerveldt-350 tube shunt make coin toss . Pre-operative data collection : The follow data collect 3 month prior surgery : date birth , gender , race , glaucoma diagnosis etiology , past ocular history ( diagnosis , surgical laser procedure ) , best correct visual acuity , intraocular pressure , glaucoma medication use , abnormal slit lamp finding , abnormal fundus exam finding . Surgical Procedure : The surgical procedure use AVB Study standardize , complication surgery note defined . Ahmed FP7 valve implantation : A superior inferior corneal traction suture 8-0 Vicryl place globe fixation require . A 90-degree conjunctival peritomy follow blunt dissection mobilize fornix limbus-based conjunctival flap area intend device implantation . Non-preserved lidocaine 1 % injected conjunctival flap , posteriorly , extraocular muscle belly blunt cannula . Gentle cautery use obtain hemostasis . The Ahmed Glaucoma Valve model FP-7 prim balanced salt solution , place intend quadrant . The plate suture sclera 8-10mm posterior limbus two 8-0 10-0 Nylon suture . A paracentesis make require , viscoelastic agent use form anterior chamber . A 22-gauge needle use create needle tract anterior chamber . The tube trim , place anterior chamber needle tract . The tube attach sclera use 10-0 Nylon suture require . A sclera corneal graft place tube suture sclera 10-0 Nylon . The conjunctival flap close 8-0 10-0 Vicryl suture . At conclusion case , Maxitrol ointment place eye . No patient patch , although shield give patient . That day , patient start antibiotic steroid eye drop . A cycloplegic use indicate . Baerveldt-350 tube shunt implantation : A superior inferior corneal traction suture 8-0 Vicryl place globe fixation . A 90 120-degree conjunctival peritomy follow blunt dissection mobilize fornix limbus-based conjunctival flap area intend device implantation . Non-preserved lidocaine 1 % injected conjunctival flap , posteriorly , extraocular muscle belly blunt cannula . Gentle cautery use obtain hemostasis . Both adjacent extraocular muscle isolate use muscle hook . 4-0 silk suture use fixation necessary . The Baerveldt drainage device model BG101-350 check balanced salt solution , 4-0 Nylon releasable intraluminal suture place . A 7-0 8-0 Vicryl ligature suture place around tube . The plate place intend quadrant muscle belly . The plate suture sclera 8-12mm posterior limbus two 8-0 10-0 Nylon suture . A paracentesis make require , viscoelastic agent use form anterior chamber . A 22-gauge needle use create needle tract anterior chamber . The tube trim , place anterior chamber needle tract . The tube attach sclera use 10-0 Nylon suture require . A sclera corneal graft place tube suture sclera . The conjunctival flap close 8-0 10-0 Vicryl suture . At conclusion case , Atropine 1 % drop Maxitrol ointment place eye . No patient patch , although shield give patient . On day surgery , patient start antibiotic steroid eye drop . A cycloplegic agent use indicate . Post-operative data collection : Patients see post-operatively minimum 1 day , 1 week , 2 week , 1 month , 2 month , 3 month , 6 month , 12 month , 18 month 2 year , 3 year , 4 year 5 year . Further visit make deemed necessary . At visit , follow data collect : 1 . Intraocular pressure ( IOP ) Goldmann Applanation Tonometry 2 . Visual Acuity ( VA ) use Snellen Chart Low Vision Chart 3 . Glaucoma Medication Use 4 . Slit Lamp Biomicroscopy &amp; Ophthalmoscopy 5 . Complications Surgery 6 . Interventions/Treatment Complications Outcome measure : Based upon pre-operative data post-operative result , study outcome assign patient , define : Complete Success : ( require follow criterion ) 1 . IOP : 5 mmHg &lt; = IOP &lt; = 18 mmHg reduction IOP 20 % great baseline every visit 3 month . 2 . Medications : No anti-glaucoma medication require . 3 . Complications : No vision threaten complication related implant/surgery . 4 . Interventions : No additional glaucoma surgery laser procedure allow . 5 . Vision : No great double mean angle resolution ( logMAR ) , correspond approximately 2 Snellen line . Qualified Success : ( require follow criterion ) 1 . IOP : 5 mmHg &lt; = IOP &lt; = 18 mmHg reduction IOP 20 % great baseline , two consecutive visit 3 month meet criterion . 2 . Medications : Anti-glaucoma medication may use . 3 . Surgery/Complications : No vision threaten complication surgery occur implantation GDD . 4 . Interventions : Surgical laser intervention correct non-vision threatening complication implant/surgery allow , additional glaucoma procedure allow . 5 . Vision : No progression light perception . Failure : ( follow criterion meet ) 1 . IOP : IOP &lt; 5 mmHg &gt; 18 mmHg reduction &lt; 20 % pre-operative IOP two consecutive visit 3 month . 2 . Surgery/Complications : Vision threaten complication surgery require related implant . This include severe choroidal effusion require drainage , suprachoroidal hemorrhage , endophthalmitis malignant glaucoma require surgery . 3 . Interventions : An additional glaucoma procedure require ( e.g . cyclodestruction , gold shunt implantation ) . 4 . Vision : Progression light perception . AVB Study publication date : 1 . Christakis PG , Tsai JC , Zurakowski D , Kalenak JW , Cantor LB , Ahmed IK . `` The Ahmed Versus Baerveldt Study : Design , baseline patient characteristic intraoperative complication '' . Ophthalmology . Nov 2011 ; 118 ( 11 ) : 2172-2179 . 2 . Christakis PG , Kalenak JW , Zurakowski D , Tsai JC , Kammer JA , Harasymowycz PJ , Ahmed IK . `` The Ahmed Versus Baerveldt Study : One year treatment outcome '' . Ophthalmology . Nov 2011 ; 118 ( 11 ) : 2180-2189 . 3 . Christakis PG , Tsai JC , Kalenak JW , Zurakowski D , Cantor LB , Kammer JA , Ahmed IK . `` The Ahmed Versus Baerveldt Study : Three year treatment outcome '' . Ophthalmology . Nov 2013 ; 120 ( 11 ) 2232-2240 .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Age great equal 18 . Inadequately controlled glaucoma determine intraocular pressure ( IOP ) great target , respond conventional medical surgical therapy . Patients significant conjunctival scar highrisk disease ( active neovascular glaucoma ) preclude antimetabolite trabeculectomy include study . Provide write informed consent participate study . Age less 18 . Patient undergo additional procedure time glaucoma drainage device implantation ( i.e . lensectomy , penetrate keratoplasty ) No light perception vision . Patient already enrol study contralateral eye . Patient unwilling unable provide inform consent participate study , adhere study requirement include implant randomization require followup visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Glaucoma Drainage Device</keyword>
	<keyword>Aqueous Shunt Implant</keyword>
	<keyword>Ahmed Valve</keyword>
	<keyword>Baerveldt Tube</keyword>
	<keyword>Refractory Glaucoma</keyword>
</DOC>